{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:15:12Z","timestamp":1774671312941,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["seminperinat.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1053\/j.semperi.2014.08.013","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T00:47:38Z","timestamp":1411433258000},"page":"516-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Prevention of preterm delivery with 17-hydroxyprogesterone caproate: Pharmacologic considerations"],"prefix":"10.1053","volume":"38","author":[{"given":"Maisa","family":"Feghali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raman","family":"Venkataramanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Caritis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1053\/j.semperi.2014.08.013_bib1","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semperi.2014.08.013_bib2","first-page":"1","article-title":"Recent declines in infant mortality in the United States, 2005\u20132011","volume":"120","author":"MacDorman","year":"2013","journal-title":"NCHS Data Brief"},{"issue":"suppl 3","key":"10.1053\/j.semperi.2014.08.013_bib3","first-page":"136","article-title":"Preterm births\u2014United States, 2006 and 2010.","volume":"62","author":"Martin","year":"2013","journal-title":"Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1053\/j.semperi.2014.08.013_bib4","first-page":"1","article-title":"Births: preliminary data for 2012. National vital statistics reports","volume":"62","author":"Hamilton","year":"2013","journal-title":"Natl Vital Stat Syst"},{"key":"10.1053\/j.semperi.2014.08.013_bib5","first-page":"159","article-title":"The \u2018see-saw\u2019 theory of parturition","volume":"47","author":"Csapo","year":"1977","journal-title":"Ciba Found Symp"},{"key":"10.1053\/j.semperi.2014.08.013_bib6","first-page":"5","article-title":"Parturition in the sheep","volume":"47","author":"Liggins","year":"1977","journal-title":"Ciba Found Symp"},{"issue":"suppl 16","key":"10.1053\/j.semperi.2014.08.013_bib7","first-page":"85","article-title":"The physiological roles of progesterone, oestradiol-17 and prostaglandin F 2 in the control of ovine parturition","volume":"16","author":"Liggins","year":"1972","journal-title":"J Reprodand Fertil"},{"issue":"2","key":"10.1053\/j.semperi.2014.08.013_bib8","first-page":"89","article-title":"Maternal plasma and amniotic fluid 17 beta-estradiol, progesterone and cortisol concentrations in women with successfully and unsuccessfully treated preterm labor","volume":"258","author":"Mazor","year":"1996","journal-title":"Arch GynecolObstet"},{"issue":"3","key":"10.1053\/j.semperi.2014.08.013_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1071-5576(02)00144-2","article-title":"Progesterone receptor localization and isoforms in myometrium, decidua, and fetal membranes from rhesus macaques: evidence for functional progesterone withdrawal at parturition","volume":"9","author":"Haluska","year":"2002","journal-title":"J Soc Gynecol Invest"},{"issue":"2","key":"10.1053\/j.semperi.2014.08.013_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1471-0528.1990.tb01740.x","article-title":"Progestogen administration in pregnancy may prevent preterm delivery","volume":"97","author":"Keirse","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"10.1053\/j.semperi.2014.08.013_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.12.042","article-title":"17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial","volume":"204","author":"Combs","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1053\/j.semperi.2014.08.013_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/AOG.0b013e31822ad6aa","article-title":"17 \u03b1-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial","volume":"118","author":"Lim","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1053\/j.semperi.2014.08.013_bib13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa070641","article-title":"A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins","volume":"357","author":"Rouse","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.semperi.2014.08.013_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.09.013","article-title":"17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm","volume":"207","author":"Grobman","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"2 Pt 1","key":"10.1053\/j.semperi.2014.08.013_bib15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/AOG.0b013e318193c677","article-title":"Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial","volume":"113","author":"Caritis","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1053\/j.semperi.2014.08.013_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.06.016","article-title":"Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial","volume":"203","author":"Combs","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1053\/j.semperi.2014.08.013_bib17","first-page":"963","article-title":"ACOG Committee Opinion number 419 October 2008 (replaces no. 291, November 2003). Use of progesterone to reduce preterm birth","volume":"112","author":"Society for Maternal-Fetal Medicine Publications Committee waoVB","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1053\/j.semperi.2014.08.013_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ajog.2012.03.010","article-title":"Progesterone and preterm birth prevention: translating clinical trials data into clinical practice","volume":"206","author":"Society for Maternal-Fetal Medicine Publications Committee waoVB","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1053\/j.semperi.2014.08.013_bib19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1479-828X.2007.00803.x","article-title":"Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial","volume":"48","author":"Borna","year":"2008","journal-title":"AustN Z J Obstet Gynaecol"},{"issue":"5","key":"10.1053\/j.semperi.2014.08.013_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2006.09.009","article-title":"Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate","volume":"196","author":"Facchinetti","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1053\/j.semperi.2014.08.013_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.12.026","article-title":"Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial","volume":"206","author":"Rozenberg","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.08.013_bib22","first-page":"208","article-title":"Hydroxyprogesterone caproate","volume":"4","author":"Florey","year":"1975"},{"issue":"4","key":"10.1053\/j.semperi.2014.08.013_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86882","article-title":"Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression","volume":"27","author":"Kuehl","year":"2001","journal-title":"Nat Genet"},{"issue":"5","key":"10.1053\/j.semperi.2014.08.013_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.08.015","article-title":"Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation","volume":"207","author":"Caritis","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1053\/j.semperi.2014.08.013_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.09.021","article-title":"Effect of endogenous steroid hormones on 17-alpha-hydroxyprogesterone caproate metabolism","volume":"208","author":"Cuppett","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1053\/j.semperi.2014.08.013_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.03.028","article-title":"Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation","volume":"205","author":"Caritis","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1053\/j.semperi.2014.08.013_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.07.009","article-title":"The effect of treatment with 17 alpha-hydroxyprogesterone caproate on changes in cervical length over time","volume":"201","author":"Durnwald","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1053\/j.semperi.2014.08.013_bib28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/uog.7338","article-title":"Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial","volume":"34","author":"O\u05f3Brien","year":"2009","journal-title":"UltrasoundObstet Gynecol"},{"issue":"1","key":"10.1053\/j.semperi.2014.08.013_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/uog.9017","article-title":"Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"38","author":"Hassan","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"11","key":"10.1053\/j.semperi.2014.08.013_bib30","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1177\/1933719109340926","article-title":"The effect of progesterone on myometrial contractility, potassium channels, and tocolytic efficacy","volume":"16","author":"Anderson","year":"2009","journal-title":"Reprod Sci"},{"issue":"4","key":"10.1053\/j.semperi.2014.08.013_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.06.085","article-title":"Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions","volume":"199","author":"Ruddock","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1053\/j.semperi.2014.08.013_bib32","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.1210\/jc.2005-0210","article-title":"Progestin suppresses thrombin- and interleukin-1beta-induced interleukin-11 production in term decidual cells: implications for preterm delivery","volume":"90","author":"Cakmak","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1053\/j.semperi.2014.08.013_bib33","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1210\/me.2006-0112","article-title":"Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-kappaB activation of cyclooxygenase 2 expression","volume":"20","author":"Hardy","year":"2006","journal-title":"Mol Endocrinol"},{"issue":"2","key":"10.1053\/j.semperi.2014.08.013_bib34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/1933719110382305","article-title":"Progesterone modulates integrin {alpha}2 (ITGA2) and {alpha}11 (ITGA11) in the pregnant cervix","volume":"18","author":"Ji","year":"2011","journal-title":"Reprod Sci"},{"issue":"1","key":"10.1053\/j.semperi.2014.08.013_bib35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1095\/biolreprod.102.013698","article-title":"Progesterone represses interleukin-8 and cyclo-oxygenase-2 in human lower segment fibroblast cells and amnion epithelial cells","volume":"69","author":"Loudon","year":"2003","journal-title":"Biol Reprod"},{"issue":"6","key":"10.1053\/j.semperi.2014.08.013_bib36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1369\/jhc.5A6759.2006","article-title":"Effects of progesterone on iNOS, COX-2, and collagen expression in the cervix","volume":"54","author":"Marx","year":"2006","journal-title":"J Histochem Cytochem"},{"issue":"3","key":"10.1053\/j.semperi.2014.08.013_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.01.007","article-title":"Progesterone protects fetal chorion and maternal decidua cells from calcium-induced death","volume":"196","author":"Murtha","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1053\/j.semperi.2014.08.013_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.01.029","article-title":"Preventing cervical ripening: the primary mechanism by which progestational agents prevent preterm birth?","volume":"198","author":"Xu","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.08.013_bib39","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1749-6632.1995.tb31380.x","article-title":"Mechanism of action of antiprogestins in the pregnant uterus","volume":"761","author":"Chwalisz","year":"1995","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1053\/j.semperi.2014.08.013_bib40","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.ajog.2005.11.026","article-title":"Mifepristone-induced cervical ripening: structural, biomechanical, and molecular events","volume":"194","author":"Clark","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1053\/j.semperi.2014.08.013_bib41","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1177\/153537020222701104","article-title":"Mechanism of action of progesterone antagonists","volume":"227","author":"Leonhardt","year":"2002","journal-title":"Exp Biol Med"},{"issue":"4","key":"10.1053\/j.semperi.2014.08.013_bib42","first-page":"1100","article-title":"Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression","volume":"80","author":"Lockwood","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1053\/j.semperi.2014.08.013_bib43","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ajog.2006.06.040","article-title":"Characterization of progesterone receptor isoform expression in fetal membranes","volume":"195","author":"Mills","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1053\/j.semperi.2014.08.013_bib44","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/j.1460-2075.1990.tb08280.x","article-title":"Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B","volume":"9","author":"Kastner","year":"1990","journal-title":"EMBO J"},{"issue":"1\u20132","key":"10.1053\/j.semperi.2014.08.013_bib45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0303-7207(01)00465-8","article-title":"Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice","volume":"179","author":"Conneely","year":"2001","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"10.1053\/j.semperi.2014.08.013_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.04.011","article-title":"Progesterone receptor isoforms profile, modulate matrix metalloproteinase 2 expression in the decidua","volume":"197","author":"Goldman","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1053\/j.semperi.2014.08.013_bib47","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2007-0077","article-title":"Nuclear progesterone receptors in the human pregnancy myometrium: evidence that parturition involves functional progesterone withdrawal mediated by increased expression of progesterone receptor-A","volume":"92","author":"Merlino","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.semperi.2014.08.013_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-2999(01)01189-X","article-title":"Progesterone receptor isoform A inhibits isoform B-mediated transactivation in human amnion","volume":"427","author":"Pieber","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1053\/j.semperi.2014.08.013_bib49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1933719107310990","article-title":"Single nucleotide polymorphisms in the human progesterone receptor gene and spontaneous preterm birth","volume":"15","author":"Guoyang","year":"2008","journal-title":"Reprod Sci"},{"issue":"4","key":"10.1053\/j.semperi.2014.08.013_bib50","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/AOG.0b013e3181d53b83","article-title":"Progesterone receptor genotype, family history, and spontaneous preterm birth","volume":"115","author":"Manuck","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1053\/j.semperi.2014.08.013_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.03.048","article-title":"Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate","volume":"205","author":"Manuck","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1053\/j.semperi.2014.08.013_bib52","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1203\/PDR.0b013e3181567bfc","article-title":"Evaluation of fetal and maternal genetic variation in the progesterone receptor gene for contributions to preterm birth","volume":"62","author":"Ehn","year":"2007","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1053\/j.semperi.2014.08.013_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2013.10.008","article-title":"Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth","volume":"210","author":"Caritis","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1053\/j.semperi.2014.08.013_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.08.001","article-title":"Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation","volume":"207","author":"Caritis","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1053\/j.semperi.2014.08.013_bib55","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1124\/dmd.109.029918","article-title":"Metabolism of 17alpha-hydroxyprogesterone caproate, an agent for preventing preterm birth, by fetal hepatocytes","volume":"38","author":"Sharma","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1053\/j.semperi.2014.08.013_bib56","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.bcp.2008.01.013","article-title":"Metabolism of 17alpha-hydroxyprogesterone caproate by hepatic and placental microsomes of human and baboons","volume":"75","author":"Yan","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1053\/j.semperi.2014.08.013_bib57","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/0002-9378(93)90296-U","article-title":"Genital and nongenital teratogenesis of prenatal progestogen therapy: the effects of 17 alpha-hydroxyprogesterone caproate on embryonic and fetal development and endochondral ossification in the C57B1\/6J mouse","volume":"169","author":"Carbone","year":"1993","journal-title":"Am J Obstetrics Gynecol"},{"key":"10.1053\/j.semperi.2014.08.013_bib58","first-page":"359","article-title":"Assay of progestins for fetal virilizing properties using the mouse","volume":"23","author":"Johnstone","year":"1964","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1053\/j.semperi.2014.08.013_bib59","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/tera.1420280208","article-title":"Evaluation of the teratogenic potential of delalutin (17 alpha-hydroxyprogesterone caproate) in mice","volume":"28","author":"Seegmiller","year":"1983","journal-title":"Teratology"},{"issue":"2","key":"10.1053\/j.semperi.2014.08.013_bib60","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1530\/acta.0.0280129","article-title":"Research on the maintenance of pregnancy by 17 alpha-hydroxyprogesterone caproate in the castrated pregnant rabbit","volume":"28","author":"Suchowsky","year":"1958","journal-title":"Acta Endocrinol"},{"issue":"1","key":"10.1053\/j.semperi.2014.08.013_bib61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0020-7292(82)90039-X","article-title":"Evaluation of the use of Proluton-Depot (hydroxyprogesterone hexanoate) in early pregnancy","volume":"20","author":"Varma","year":"1982","journal-title":"Int Gynaecol Obstet"},{"issue":"1","key":"10.1053\/j.semperi.2014.08.013_bib62","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/tera.1420270109","article-title":"Prospective study of suspected associations between certain drugs administered during early pregnancy and congenital malformations","volume":"27","author":"Michaelis","year":"1983","journal-title":"Teratology"},{"issue":"4","key":"10.1053\/j.semperi.2014.08.013_bib63","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0015-0282(16)48490-6","article-title":"Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936\u20131974","volume":"43","author":"Resseguie","year":"1985","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1053\/j.semperi.2014.08.013_bib64","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0015-0282(16)49292-7","article-title":"The risk of fetal anomalies as a result of progesterone therapy during pregnancy","volume":"45","author":"Check","year":"1986","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1053\/j.semperi.2014.08.013_bib65","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/01.AOG.0000281348.51499.bc","article-title":"Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo","volume":"110","author":"Northen","year":"2007","journal-title":"Obstet Gynecol"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000514001013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000514001013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T04:26:48Z","timestamp":1565843208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000514001013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0146000514001013"],"URL":"https:\/\/doi.org\/10.1053\/j.semperi.2014.08.013","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of preterm delivery with 17-hydroxyprogesterone caproate: Pharmacologic considerations","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semperi.2014.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}